BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 10078002)

  • 1. [Systemic sclerosis: different subsets and disease remitting drugs].
    Ogawa T; Saito E
    Nihon Rinsho; 1999 Feb; 57(2):344-8. PubMed ID: 10078002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Systemic sclerosis--clinical course and treatment possibilities].
    Szymańska E; Maj M; Rudnicka L
    Przegl Lek; 2005; 62(12):1538-41. PubMed ID: 16786791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Systemic sclerosis].
    Gustafsson R
    Nord Med; 1994; 109(8-9):236-7. PubMed ID: 7937033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoantibody profile in systemic sclerosis.
    Behmanesh F; Amin R; Khajedaluee M; Fritzler MJ
    Acta Med Iran; 2010; 48(1):12-20. PubMed ID: 21137663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenic autoantibodies in systemic sclerosis.
    Gabrielli A; Svegliati S; Moroncini G; Avvedimento EV
    Curr Opin Immunol; 2007 Dec; 19(6):640-5. PubMed ID: 18083509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic sclerosis sine scleroderma: demographic, clinical, and serologic features and survival in forty-eight patients.
    Poormoghim H; Lucas M; Fertig N; Medsger TA
    Arthritis Rheum; 2000 Feb; 43(2):444-51. PubMed ID: 10693887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic sclerosis/scleroderma: a treatable multisystem disease.
    Hinchcliff M; Varga J
    Am Fam Physician; 2008 Oct; 78(8):961-8. PubMed ID: 18953973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoantibodies in systemic sclerosis.
    Steen VD
    Semin Arthritis Rheum; 2005 Aug; 35(1):35-42. PubMed ID: 16084222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted therapy for systemic sclerosis.
    Steen V
    Autoimmun Rev; 2006 Feb; 5(2):122-4. PubMed ID: 16431341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic sclerosis.
    Ng SC
    Singapore Med J; 1992 Apr; 33(2):189-92. PubMed ID: 1621127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic sclerosis-scleroderma.
    Haustein UF
    Dermatol Online J; 2002 Jun; 8(1):3. PubMed ID: 12165213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [How to recognize scleroderma].
    Francès C; Ayoub N; Barete S
    Rev Prat; 2002 Nov; 52(17):1884-90. PubMed ID: 12532864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Renal involvement in systemic sclerosis].
    Guerini S; Cavazzana I; Venturelli C; Rozzi M; Turina S; Sottini L; Tardanico R; Franceschini F; Scolari F
    G Ital Nefrol; 2007; 24(4):295-310. PubMed ID: 17659501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Scleroderma (progressive systemic sclerosis, PSS); pathophysiological, clinical and pharmacological aspects of the syndrome.
    Herbai G
    Acta Med Acad Sci Hung; 1978; 35(3-4):201-11. PubMed ID: 756110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic sclerosis sine scleroderma.
    Kucharz EJ; Kopeć-Mędrek M
    Adv Clin Exp Med; 2017 Aug; 26(5):875-880. PubMed ID: 29068586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Juvenile scleroderma].
    de Mâcedo PA; Shinjo SK; Goldenstein-Schainberg C
    Acta Reumatol Port; 2008; 33(3):289-97. PubMed ID: 18846006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoantibody profiles in systemic sclerosis: predictive value for clinical evaluation and prognosis.
    Hamaguchi Y
    J Dermatol; 2010 Jan; 37(1):42-53. PubMed ID: 20175839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud's phenomenon to systemic sclerosis: a twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis.
    Koenig M; Joyal F; Fritzler MJ; Roussin A; Abrahamowicz M; Boire G; Goulet JR; Rich E; Grodzicky T; Raymond Y; Senécal JL
    Arthritis Rheum; 2008 Dec; 58(12):3902-12. PubMed ID: 19035499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoantibodies against nuclear, nucleolar, and mitochondrial antigens in systemic sclerosis (scleroderma).
    Reimer G
    Rheum Dis Clin North Am; 1990 Feb; 16(1):169-83. PubMed ID: 2406806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe organ involvement in systemic sclerosis with diffuse scleroderma.
    Steen VD; Medsger TA
    Arthritis Rheum; 2000 Nov; 43(11):2437-44. PubMed ID: 11083266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.